Vertex will make $21bn from cystic fibrosis drug
The US company, Vertex, is claiming that it must price its cystic fibrosis drug, Orkambi, at a high level to … Read more
The US company, Vertex, is claiming that it must price its cystic fibrosis drug, Orkambi, at a high level to … Read more
NHS England has been accused by a charity of “abandoning” thousands of people to a potential death sentence by rationing … Read more
GP leaders slammed the ‘rationing’ of NHS services and warned that the restrictions on access to care appeared to breach … Read more